As previously reported, NF-κB inhibitor treatment significantly increases the chemosensitivity of the colon cancer cell line HT-29, and it effectively inhibits cell proliferation and induces apoptosis when used in combination with chemotherapeutic drugs [35]. The gene discussed is NFKB1; the disease is colonic neoplasm.